Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 21, 2024 - Issue 1
Submit an article Journal homepage
965
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity

Sophia Eilat-Tsanania Department of Family Medicine, Clalit Health Services, North District, Israel;b Department of Family Medicine, Azrieli Faculty of Medicine, Bar-Ilan University, Ramat Gan, Israel;c Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, CanadaView further author information
,
Pierre Ernstc Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, Canada;d Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, CanadaView further author information
&
Samy Suissac Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, Canada;d Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, CanadaCorrespondence[email protected]
View further author information
Article: 2327345 | Received 05 Feb 2024, Accepted 01 Mar 2024, Published online: 20 Mar 2024

References

  • Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur Respir J. 2023;61(4):1. doi:10.1183/13993003.00239-2023.
  • Santos N, Miravitlles M, Camelier AA, et al. Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: a systematic review. Tuberc Respir Dis (Seoul). 2022;85(3):205–3. doi:10.4046/trd.2021.0179.
  • Lipson DA, Barnhart F, Brealey N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378(18):1671–1680. doi:10.1056/NEJMoa1713901.
  • Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;383(1):35–48. doi:10.1056/NEJMoa1916046.
  • Divo M, Celli BR. Multimorbidity in patients with chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):405–419. doi:10.1016/j.ccm.2020.06.002.
  • Suissa S, Dell’Aniello S, Ernst P. Single-Inhaler triple versus dual bronchodilator therapy in COPD: real-world comparative effectiveness and safety. Int J Chron Obstruct Pulmon Dis. 2022;volume17:1975–1986. doi:10.2147/COPD.S378486.
  • Zhu Z, Li J, Si J, et al. A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity. Eur Respir J. 2021;58(4):2100199. doi:10.1183/13993003.00199-2021.
  • Berbudi A, Rahmadika N, Tjahjadi AI, et al. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442–449. doi:10.2174/1573399815666191024085838.
  • Llorente L, De La Fuente H, Richaud-Patin Y, et al. Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology. Immunol Lett. 2000;74(3):239–244. doi:10.1016/s0165-2478(00)00255-8.
  • Hughes MJ, McGettrick HM, Sapey E. Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target. Eur Respir Rev. 2020;29(155):190102. doi:10.1183/16000617.0102-2019.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.